Tesamorelin mitigates this through pulsatile release (avoiding the sustained supraphysiological GH levels that direct injection creates), and clinical trials in type 2 diabetic patients showed no significant changes in glucose control
Going by sensation alone, Id say the results were noticeable although minimal
Although GLP-1s were originally developed to treat diabetes, they have quickly been co-opted for weight loss, leading to shortages for patients
Boosts the metabolism Promotes weight loss Effectively removes fat from the liver Significantly increases energy levels Converts carbohydrates into energy Enhances mood Helps controlling cholesterol levels Improves skin tone The injections help to reduce excess fat in certain areas of the body, as well as increase metabolic activity and energy
However, significant restraints persist, particularly the premium pricing of these therapies and limited insurance coverage in emerging markets, which restricts patient access
Lastly, its wise to consult with your healthcare provider